B-CELL APLASIA

This adverse event was reported 258 times

B-CELL APLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AXICABTAGENE CILOLEUCEL 46 0.0045
1 BREXUCABTAGENE AUTOLEUCEL 8 0.0037
2 BLINATUMOMAB 32 0.0030
3 LISOCABTAGENE MARALEUCEL 2 0.0023
4 PROPARACAINE HYDROCHLORIDE 1 0.0019
5 ISRADIPINE 1 0.0018
6 IDECABTAGENE VICLEUCEL 2 0.0016
7 SILTUXIMAB 1 0.0015
8 I. V. FAT EMULSION 1 0.0014
9 INOTUZUMAB OZOGAMICIN 4 0.0013
See all drugs enriched for association with B-CELL APLASIA